Literature DB >> 25390318

Randomised controlled trials for Ebola: practical and ethical issues.

Clement Adebamowo1, Oumou Bah-Sow2, Fred Binka3, Roberto Bruzzone4, Arthur Caplan5, Jean-François Delfraissy6, David Heymann7, Peter Horby8, Pontiano Kaleebu9, Jean-Jacques Muyembe Tamfum10, Piero Olliaro11, Peter Piot12, Abdul Tejan-Cole13, Oyewale Tomori14, Aissatou Toure15, Els Torreele16, John Whitehead17.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25390318      PMCID： PMC4392883          DOI： 10.1016/S0140-6736(14)61734-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Evaluating novel therapies during the Ebola epidemic.

Authors:  Steven Joffe
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272
  1 in total
  52 in total

1.  Vaccine testing. Ebola and beyond.

Authors:  Marc Lipsitch; Nir Eyal; M Elizabeth Halloran; Miguel A Hernán; Ira M Longini; Eli N Perencevich; Rebecca F Grais
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

2.  Evolving Challenges and Research-Needs Concerning Ebola.

Authors:  Robert Klitzman
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

3.  Situating the trovan trial with the use of experimental ebola therapies is like comparing an apple with an orange.

Authors:  Muhammed O Afolabi
Journal:  J Bioeth Inq       Date:  2015-02-05       Impact factor: 1.352

4.  Selecting the right tool for the job.

Authors:  Arthur L Caplan; Carolyn Plunkett; Bruce Levin
Journal:  Am J Bioeth       Date:  2015       Impact factor: 11.229

5.  Rigorous Clinical Trial Design in Public Health Emergencies Is Essential.

Authors:  Susan S Ellenberg; Gerald T Keusch; Abdel G Babiker; Kathryn M Edwards; Roger J Lewis; Jens D Lundgren; Charles D Wells; Fred Wabwire-Mangen; Keith P W J McAdam
Journal:  Clin Infect Dis       Date:  2018-04-17       Impact factor: 9.079

6.  Unproven Stem Cell-Based Interventions: Advancing Policy through Stakeholder Collaboration.

Authors:  Kirstin R W Matthews; Ana S Iltis
Journal:  Tex Heart Inst J       Date:  2017-06-01

7.  Ethical Considerations in Microbial Therapeutic Clinical Trials.

Authors:  Michael H Woodworth; Kaitlin L Sitchenko; Cynthia Carpentieri; Rachel J Friedman-Moraco; Tiffany Wang; Colleen S Kraft
Journal:  New Bioeth       Date:  2017-10-17

8.  A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies.

Authors:  Alexander M Kaizer; Brian P Hobbs; Joseph S Koopmeiners
Journal:  Biometrics       Date:  2018-01-22       Impact factor: 2.571

9.  [Ethical and health issues posed by the recent Ebola epidemic: What should we learn?].

Authors:  Juan Pablo Beca; Sofía P Salas
Journal:  Rev Med Chil       Date:  2016-03       Impact factor: 0.553

Review 10.  Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks.

Authors:  Azizul Haque; Didier Hober; Joel Blondiaux
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.